Cargando…
Daratumumab: new indications revolving around "off-targets"
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634197/ https://www.ncbi.nlm.nih.gov/pubmed/34348458 http://dx.doi.org/10.3324/haematol.2021.279487 |
_version_ | 1784608088980979712 |
---|---|
author | Ofran, Yishai |
author_facet | Ofran, Yishai |
author_sort | Ofran, Yishai |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8634197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-86341972021-12-17 Daratumumab: new indications revolving around "off-targets" Ofran, Yishai Haematologica Editorials Fondazione Ferrata Storti 2021-12-01 /pmc/articles/PMC8634197/ /pubmed/34348458 http://dx.doi.org/10.3324/haematol.2021.279487 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Editorials Ofran, Yishai Daratumumab: new indications revolving around "off-targets" |
title | Daratumumab: new indications revolving around "off-targets" |
title_full | Daratumumab: new indications revolving around "off-targets" |
title_fullStr | Daratumumab: new indications revolving around "off-targets" |
title_full_unstemmed | Daratumumab: new indications revolving around "off-targets" |
title_short | Daratumumab: new indications revolving around "off-targets" |
title_sort | daratumumab: new indications revolving around "off-targets" |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634197/ https://www.ncbi.nlm.nih.gov/pubmed/34348458 http://dx.doi.org/10.3324/haematol.2021.279487 |
work_keys_str_mv | AT ofranyishai daratumumabnewindicationsrevolvingaroundofftargets |